New liquid metformin launched by Rosemont

12 August 2007

A newly-licensed liquid version of metformin HCl is now available from Rosemont Pharmaceuticals, whose 150ml liquid 500mg/5ml formulation has just been granted a licence by the UK's Medicines and Healthcare products Regulatory Agency (MHRA).

Rosemont's liquid metformin HCl carries a distinctive new look which will set it apart from other liquid medicines, the company claims. The extensive Rosemont medicines range is undergoing a major transformation. Each pack will be color coded and also carry a symbol to indicate for which therapeutic area the product is indicated - based on the familiar disease categories set out in MIMS and the British National Formulary, for example. Over the course of the next 18 months, all 98 Rosemont liquid medicines - both licensed and specials will appear in new packaging.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight